0001179110-15-008413.txt : 20150522 0001179110-15-008413.hdr.sgml : 20150522 20150522073202 ACCESSION NUMBER: 0001179110-15-008413 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150520 FILED AS OF DATE: 20150522 DATE AS OF CHANGE: 20150522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peacock Jonathan M CENTRAL INDEX KEY: 0001500241 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 15884510 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 4 1 edgar.xml FORM 4 - X0306 4 2015-05-20 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001500241 Peacock Jonathan M C/O BELLEROPHON THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827 1 1 0 0 President and CEO Common Stock 2015-05-20 4 P 0 5560 8.6912 A 26427 D The price reported represents the weighted average sales price of shares purchased in multiple transactions at prices ranging from $8.39 to $8.93 per share. The reporting person hereby undertakes, upon the request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. /s/ Manesh Naidu, as Attorney-in-Fact for Jonathan M. Peacock 2015-05-22